SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

The impact of HPV vaccination on future cervical screening: a simulation study of two birth cohorts in Denmark

By

Authors:  Mie Sara Hestbech, Elsebeth Lynge, Jakob Kragstrup, Volkert Siersma, Miguel Vazquez-Prada Baillet, John Broderson Abstract: Objectives To explore the interplay between primary and secondary prevention of cervical cancer by estimating future screening outcomes in women offered human papillomavirus (HPV) vaccination when they were sexually naïve. Design Estimation of outcome of liquid-based cytology screening for a post-HPV vaccination […]

[Continue reading...]

Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase

By Leave a Comment

Authors: Rebecca E. Chandler, Kristina Juhlin, Jonas Fransson, Ola Caster, I. Ralph Edwards, G. Niklas Norén Abstract: Introduction A number of safety signals—complex regional pain syndrome (CRPS), postural orthostatic tachycardia syndrome (POTS), and chronic fatigue syndrome (CFS)—have emerged with human papillomavirus (HPV) vaccines, which share a similar pattern of symptomatology. Previous signal evaluations and epidemiological studies have largely relied on traditional methodologies and signals have been […]

[Continue reading...]

Immunological studies of cerebrospinal fluid from patients with CNS symptoms after human papillomavirus vaccination

By 4 Comments

Immunological studies of cerebrospinal fluid from patients with CNS symptoms after human papillomavirus vaccination Highlights •32 patients with prolonged CNS symptoms after HPV vaccination were studied. •CSF levels of IL-4, IL-13, IL-17, IL-8 and MCP-1 were elevated. •CSF levels of PDGF-bb and IL-12 were decreased. •Antibodies to GluN2B-NT2, GluN2B-CT and GluN1-NT in CSF were increased. […]

[Continue reading...]

Colombia: Will there be HPV Vaccine Suspension?

By 1 Comment

Vaccine Suspension Translation by Mario Lamos Breaking News: The Attorney General’s Office appealed to the Constitutional Court asking for enforcement of a previous ruling issued by the High Court of Cali, requiring the Ministry of Health to suspend the HPV vaccination program in Colombia. The watchdog said the Constitutional Court must rule on the matter because the side […]

[Continue reading...]

Reduction in HPV Prevalence— No Evidence to Support HPV Vaccination reduces HPV Prevalence

By

Authors:  Jennifer A. Groner1, George D. Harris2 and Diane M. Harper3,4,5  TO THE EDITOR—The recent Centers for Disease Control and Prevention (CDC) study by Markowitz et al [1] provides limited and inconclusive data on 111 sexually active females between 14 and 19 years of age who received at least 1 dose of quadrivalent human papillomavirus vaccine (HPV4). The […]

[Continue reading...]

Hypothesis: Human papillomavirus vaccination syndrome

By

Hypothesis: Human papillomavirus vaccination syndrome – small fiber neuropathy and dysautonomia could be its underlying pathogenesis By Martinez-Lavin, M Abstract Vaccination has been one of the most effective public health measures in the history of medicine. However, seemingly inexplicit adverse reactions have been described after the injection of the newer vaccines vs. human papillomavirus (HPV). […]

[Continue reading...]

Autoimmune / auto inflammatory syndrome induced by (ASIA)

By

Autoimmune / auto inflammatory syndrome induced by adjuvants (ASIA) after quadrivalent human papillomavirus vaccination in Colombians: a call for personalised medicine Authors: Anaya JM1, Reyes B1, Perdomo-Arciniegas AM2, Camacho-Rodríguez B2, Rojas-Villarraga A1 Abstract This was a case study in which 3 patients with autoimmune/auto-inflammatory syndrome induced by adjuvants (ASIA) after quadrivalent human papillomavirus vaccination (HPV) were […]

[Continue reading...]

Early cervical myelitis after human papilloma virus vaccination

By Leave a Comment

Authors: Mireya Fernández-Fournier, MD, Javier Díaz de Terán, MD, Antonio Tallón Barranco, MD, PhD and Inmaculada Puertas, MD, PhD In 2006, an adjuvant vaccine against 4 human papillomavirus (HPV) types was licensed. By 2012, 45 countries had introduced HPV vaccination.1 HPV encompasses a group of more than 100 viruses, of which at least 13 are high-risk types, responsible for […]

[Continue reading...]

Postural tachycardia syndrome following human papillomavirus vaccination

By Leave a Comment

Postural tachycardia syndrome Postural tachycardia syndrome… Blitshteyn S. Author information   Abstract BACKGROUND AND PURPOSE: Postural tachycardia syndrome (POTS) is a heterogeneous disorder of the autonomic nervous system that may have an autoimmune etiology. METHODS: Six patients who developed new onset POTS 6 days to 2 months following human papillomavirus vaccination are reported. RESULTS: Three patients also […]

[Continue reading...]

South Australian women neglect Pap Smears after HPV vaccination

By Leave a Comment

vaccine science?

SaneVax:  It appears that Australia’s HPV vaccination program is going to cost the taxpayers more than originally estimated. Apparently, government health officials neglected to make it perfectly clear to medical consumers that Pap Smears are still required after being vaccinated for HPV (human papillomavirus). Now the taxpayers get to pay for an ‘educational campaign’ to […]

[Continue reading...]

Adolescents’ awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary.

By Leave a Comment

Pub Med Vaccine. 2011 Sep 19. [Epub ahead of print] Marek E, Dergez T, Rebek-Nagy G, Kricskovics A, Kovacs K, Bozsa S, Kiss I, Ember I, Gocze P. Source Department of Public Health Medicine, Medical Faculty, University of Pecs, Pecs H-7624, Hungary; Chair of Clinical Infectology and Migration Health, Medical Faculty, University of Pecs, Pecs […]

[Continue reading...]

SANE Vax to CDC: Request for additional data on HPV vaccine post-marketing monitoring

By 1 Comment

Lauri Markowitz, M.D. Centers for Disease Control and Prevention MS E05, 1600 Clifton Road Atlanta, GA 30333 lem2@cdc.govAugust 31, 2011 Dear Dr. Markowitz: Thank you for your August 29, 2011 response to my letter requesting additional information about post licensure monitoring for Gardasil™ from the CDC. Before relaying your response to medical consumers, I would […]

[Continue reading...]

Nurse’s bid to get back job fails

By Leave a Comment

From the Otago Daily Times A Northland nurse has lost her bid to the Employment Relations Authority (ERA) to get her job back after she failed to have an emergency crash kit on site while giving school students HPV vaccines. Natalie Lewers was a senior public health nurse employed by the Northland District Health Board (NDHB) to […]

[Continue reading...]

Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries

By

Wong CA, Saraiya M, Hariri S, Eckert L, Howlett RI, Markowitz LE, Brotherton JM, Sinka K, Martinez-Montañez OG, Kjaer SK, Dunne EF. Source: Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA. Abstract In this review, we describe plans to monitor the impact of human papillomavirus (HPV) vaccine on […]

[Continue reading...]

Cervarix Vaccine Programme to Cost UK Government £5.5 billion over 73 Years Before Targeted Annual Number of Women’s Lives are Saved

By Leave a Comment

By Leslie Carol Botha Let’s bypass the usual conversation on arbitrating a price on the value of a person’s life.  The Cervarix programme in the United Kingdom may become bankrupt before even saving one woman’s life from cervical cancer. Freda Birrell, Secretary of SANE Vax Inc. has been communicating with government officials in the United […]

[Continue reading...]

Demyelinating disease and vaccination of the human papillomavirus

By

[Article in Spanish] Alvarez-Soria MJ, Hernandez-Gonzalez A, Carrasco-Garcia de Leon S, Del Real-Francia MA, Gallardo-Alcaniz MJ, Lopez-Gomez JL. Source Hospital General de Ciudad Real, Ciudad Real, Espana. Abstract INTRODUCTION. Primary prevention by prophylactic vaccination against the major cause of cervical cancer, the carcinogenic human papillomavirus (HPV) types 16 and 18, is now available worldwide. Postlicensure […]

[Continue reading...]

Parents delay vaccinations

By Leave a Comment

By Rebecca Todd Canterbury parents are opting to get their daughters immunised against cervical cancer when they are older. A GP spokesman said that decision was the reason for Canterbury having the lowest Gardasil vaccination rate in the country for girls aged 12 to 14. Gardasil protects girls from a sexually transmitted infection, the human […]

[Continue reading...]

Lawmakers target preventable cancer

By Leave a Comment

Posted in JournalGazette.net Indiana loses on average one woman every three days to cervical cancer. Each week, at least two Hoosier families say goodbye to mothers, daughters, sisters and friends. National statistics show one woman dies of this disease every 2 1/2 hours. What makes these numbers saddest of all is the fact that cervical […]

[Continue reading...]

One in 300 Irish Girls Report Adverse Reactions After Gardasil

By Leave a Comment

By Norma Erickson According to a report in the Irish Times, there have been 90,000 doses of Gardasil administered since the Irish immunization program began last May. 300 adverse reactions have been reported. That means for every 300 doses administered, one girl suffered some sort of adverse event after her jab of HPV vaccine. Ireland is one of […]

[Continue reading...]

Mom's advice sways older daughters decision about HPV vaccination

By Leave a Comment

By Law Offices of Sadaka Associates Many young women rely on a key person to help them make critical decisions in life–no matter how old you get, many turn to their mothers for advice and help.  This is especially true as many head out on their own–taking their first steps of true independence when they […]

[Continue reading...]

News

Videos

Contact